Gum health may influence HIV inflammation, study finds
NCT ID NCT04645693
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at 227 people with HIV who are on antiretroviral therapy. Researchers examined their oral health—including cavities, gum disease, and dry mouth—and checked for links to metabolic problems and ongoing inflammation. The goal was to understand if poor oral health contributes to long-term health issues in people living with HIV.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this research could highlight the importance of dental care in managing long-term health for people with HIV.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot prove cause and effect, only suggest links between oral health and inflammation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
227 people
The number who actually took part.
- Started
-
Feb 2021
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients living with HIV above the age of 18 will be enrolled in this study.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥18 years * Has been diagnosed with HIV (as documented by a prior laboratory report of positive HIV-1/2 antibody and/or detectable HIV RNA, available for review by the study team) * Has received antiretroviral therapy for at least 12 months * Able and willing to provide informed consent prior to initiation of study procedures * Willing and able to comply with all study procedures, and likely to be available for the duration of the study Exclusion Criteria: * Has been diagnosed with the following xerostomia-related autoimmune conditions: Sjorgen's and sarcoidosis * Has never received radiation therapy to the head or neck (including radioactive iodine therapy) * Was taking anti-osteoporotic agents (biphosphonates, denosumab) prior to HIV diagnosis. * Women who are pregnant at the time of enrollment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Caries are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Pennsylvania School of Dental Medicine
Philadelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can 'Queen Mothers' bring HIV testing to the doorstep?
- Scientists map HIV's hiding spots in early infection
- Can a new device catch tooth decay before it becomes a cavity?
- Could popular Weight-Loss drugs quietly reshape your mouth?
- Can local clinics keep more people with HIV in care?
- Can a phone call keep HIV-Positive mothers and babies on track?